- ￥4669.01
- Tocris bioscience
- made in USA
- 5270
- 2025年11月16日
企业认证
相关产品推荐更多 >
Sigma货号R8875鱼滕精(Rotenone)上海睿安生物13611631389
￥5752.17
Sigma货号D7783-5mg吡(bǐ)咯(luò)并喹(kuí)啉醌Pyrroloquinoline quinone上海睿安生物13611631389
￥5344.12
LY-294,002 hydrochloride抑制剂Sigma货号L9908现货13611631389上海睿安生物
￥2627.40
Roche货号11359061001苯(jiǎ)磺_酰氟PMSF上海睿安生物19121878899
￥3778.35
Sigma货号721336-1g现货L-乳酸钠-3-13C溶液19121878899上海睿安生物Sigma官方正式授权代理商
￥10097.09
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
2-8°C
- 保质期：
1年
- 英文名：
Toyocamycin
- 库存：
30⁺瓶
- 供应商：
上海睿安生物19121878899
- CAS号：
606-58-6
- 规格：
50mg/瓶
Tocris货号5270-10mg现货Toyocamycin上海睿安生物19121878899
安迪Bio-Techne(R&D Systems-Tocris)官方正式授权代理商
Tocris货号5270-50mg现货Toyocamycin上海睿安生物19121878899
Chemical Name:4-Amino-7-β-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile
Purity:≥98%
Biological Activity
Toyocamycin is an adenosine analog; antifungal antibiotic. Inhibits RNA self-cleavage in HEK79 cells and PI 3-kinase activity in A431 epidermoid carcinoma cell membrane fractions. Also inhibits thapsigargin-induced XBP1-luciferase activation and induces apoptosis in multiple myeloma cell lines.Technical Data
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
- Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing.
Ri et al.
Blood.Cancer.J., 2012;2:e79 - Inhibition of phosphatidylinositol kinase by toyocamycin.
Nishioka et al.
J.Antibiot. (Tokyo)., 1990;43:1586 - Identification of inhibitors of ribozyme self-cleavage in mammalian cells via high-throughput screening of chemical libraries.
Yen et al.
RNA, 2006;12:797
Citation for Toyocamycin
The citations listed below are publications that use Tocris products. Selected citations for Toyocamycin include:
1 Citation: Showing 1 - 1
- IRE1α-XBP1 inhibitors exerted anti-tumor activities in Ewing's sarcoma.
Authors: Tanabe Et al.
Oncotarget 2018;9:14428
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Tocris货号5270-10mg现货Toyocamycin上海睿安生物19121878899
安迪Bio-Techne(R&D Systems-Tocris)官方正式授权代理商
Tocris货号5270-50mg现货Toyocamycin上海睿安生物19121878899
Chemical Name:4-Amino-7-β-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidine-5-carbonitrile
Purity:≥98%
Biological Activity
Toyocamycin is an adenosine analog; antifungal antibiotic. Inhibits RNA self-cleavage in HEK79 cells and PI 3-kinase activity in A431 epidermoid carcinoma cell membrane fractions. Also inhibits thapsigargin-induced XBP1-luciferase activation and induces apoptosis in multiple myeloma cell lines.Technical Data
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
- Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing.
Ri et al.
Blood.Cancer.J., 2012;2:e79 - Inhibition of phosphatidylinositol kinase by toyocamycin.
Nishioka et al.
J.Antibiot. (Tokyo)., 1990;43:1586 - Identification of inhibitors of ribozyme self-cleavage in mammalian cells via high-throughput screening of chemical libraries.
Yen et al.
RNA, 2006;12:797
Citation for Toyocamycin
The citations listed below are publications that use Tocris products. Selected citations for Toyocamycin include:
1 Citation: Showing 1 - 1
- IRE1α-XBP1 inhibitors exerted anti-tumor activities in Ewing's sarcoma.
Authors: Tanabe Et al.
Oncotarget 2018;9:14428
